Nesmith ended with 14 points (6-12 FG, 2-6 3Pt), one rebound, two assists and two steals in 34 minutes during Saturday's 120-118 loss to the Hawks. Nesmith has scored in double figures in eight of his ...

Nesmith was expected to suit up given his probable tag, and now that he has the green light, he should handle his regular workload in this matchup. Nesmith is averaging 14.0 points, 4.2 rebounds, 1.4 ...

INDIANAPOLIS (AP) — Aaron Nesmith scored a career-high 27 points, Pascal Siakam added 20 and the Indiana Pacers defeated the ...

All things Pacers: Latest Indiana Pacers news, schedule, roster, stats, injury updates and more. The performance marks another step toward Nesmith feeling fully like himself again as he missed 35 ...

Highlights 01 Mar 2025 00:54 Henry Thornton helped bowl South Australia to their first One-Day Cup title in 13 years with 4-27 from 9.3 overs against Victoria in the final ...

A $400 million opportunity over the next 4 years for electrification of over 5,000 fleet vehicles and supporting infrastructure throughout the state The Nuvve contract will address the SONM’s ...

In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the meeting.

its ability to protect its intellectual property and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's latest ...

WPL Live Score, Gujarat Giants vs Mumbai Indians Highlights: All-rounder Nat Sciver-Brunt starred in both departments as Mumbai Indians produced a clinical performance to return to winning ways ...

Recent Highlights Avidity will be reporting top-line del-zota data from the completed Phase 1/2 EXPLORE44 ® trial for people living with Duchenne muscular dystrophy amenable to exon 44 skipping ...

today reported financial results for the fourth quarter and full year 2024 and recent business highlights. “Our most recent clinical data for DYNE-101 from the ACHIEVE trial in DM1 patients showed ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today ...